PRELUDE THERAPEUTICS INC (PRLD) Net income 2019–2025
PRELUDE THERAPEUTICS INC (PRLD) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$99.5MFY2025 · since FY2019: -$27.6M → -$99.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$99.5M | +21.8% |
| FY2024 | -$127.2M | -4.4% |
| FY2023 | -$121.8M | -5.5% |
| FY2022 | -$115.4M | -3.4% |
| FY2021 | -$111.7M | -96.2% |
| FY2020 | -$56.9M | -106.5% |
| FY2019 | -$27.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PRLD financial trends
PRLD RevenuePRLD Net marginPRLD Gross profitPRLD Gross marginPRLD Operating incomePRLD Operating marginPRLD Operating cash flowPRLD Free cash flowPRLD Capital expendituresPRLD Return on equityPRLD Stock buybacksPRLD Dividends paidPRLD Total assetsPRLD Total liabilitiesPRLD Shareholders’ equityPRLD overview →